FR3910M - - Google Patents
Info
- Publication number
- FR3910M FR3910M FR620A FR620A FR3910M FR 3910 M FR3910 M FR 3910M FR 620 A FR620 A FR 620A FR 620 A FR620 A FR 620A FR 3910 M FR3910 M FR 3910M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR620A FR3910M (de) | 1964-12-31 | 1964-12-31 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR620A FR3910M (de) | 1964-12-31 | 1964-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR3910M true FR3910M (de) | 1966-03-11 |
Family
ID=8567079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR620A Expired FR3910M (de) | 1964-12-31 | 1964-12-31 |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR3910M (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0521344A2 (de) * | 1991-07-01 | 1993-01-07 | Altergon S.A. | Lösliche Ibuprofen- und Naproxensalze mit N-(2-Hydroxyethyl)-Pyrrolidine und diese enthaltende pharmazeutische Zusammensetzungen |
-
1964
- 1964-12-31 FR FR620A patent/FR3910M/fr not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0521344A2 (de) * | 1991-07-01 | 1993-01-07 | Altergon S.A. | Lösliche Ibuprofen- und Naproxensalze mit N-(2-Hydroxyethyl)-Pyrrolidine und diese enthaltende pharmazeutische Zusammensetzungen |
| EP0521344A3 (en) * | 1991-07-01 | 1993-04-07 | Altergon S.A. | Soluble salts of ibuprofen and naproxen with n-(2-hydroxyethyl) pyrrolidine and pharmaceutic compositions containing said salts |